Skip to content

Investigating the Effect of Nifedipine on menstrual pain

Investigating the Effect of Nifedipine on Primary Dysmenorrhea in women referred to Besath Sanandaj clinic in 2024: a double-blind randomized clinical trial study

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240910062996N1
Enrollment
120
Registered
2024-12-16
Start date
2024-11-21
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhoea

Interventions

Intervention 1: Intervention group:Nifedipine, a calcium channel blocker, 10 mg, along with 325 mg acetaminophen. At the onset of menstrual pain, one 10 mg nifedipine tablet should be taken with one 3

Sponsors

Sanandaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Women who are between 18 and 35 years old or in reproductive age. Women who have primary dysmenorrhea according to vas score and diagnosed by a clinical specialist. Have regular menstrual cycles with intervals of 21 to 35 days.

Exclusion criteria

Exclusion criteria: Be pregnant. Have heavy bleeding during menstruation. Suffering from a known chronic disease (including Migraines, Seizures, Hypertension, Diabetes, Liver and Kidney diseases, Cardiovascular diseases, Cancers, Psychiatric disorders). Having itching, burning or abnormal secretions. Have a history of Pelvic Inflammatory Disease, Myoma or Tumor. Taking other painkillers within 48 hours before the start of the studied cycle or while taking the prescribed medicine.

Design outcomes

Primary

MeasureTime frame
Crampy pain before or during menstruation. Timepoint: Before, First, Second and Third months after intervention. Method of measurement: Visual Analog Scale (VAS).

Secondary

MeasureTime frame
Quality of life or the patient's overall understanding of her health, physical and social functioning, physical, mental and emotional health, vitality and vital energy. Timepoint: Before, First, Second and Third months after intervention. Method of measurement: sf-12 questionnaire.;Physical ?Activity in terms of metabolic energy consumption. Timepoint: Before, First, Second and Third months after intervention. Method of measurement: International Physical Activity Questionnaires (IPAQ).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Rezaei

Sanandaj University of Medical Sciences

farnazrezai36@gmail.com+98 87 3362 7228

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026